Effects of ipriflavone on bone mass and calcium metabolism in postmenopausal osteoporosis
A large number of patients with postmenopausal osteoporosis (PMO), referred to 12 Italian centers, was randomly divided into 2 groups and treated with oral IP or placebo (Pl). All patients received an oral Ca supplement (1 g/day). One hundred and twenty six patients completed 1 year of the study. Bo...
Gespeichert in:
Veröffentlicht in: | Bone and mineral 1992-01, Vol.19, p.no. sul.-no. sul. |
---|---|
Hauptverfasser: | , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Schreiben Sie den ersten Kommentar!